COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,552 Articles (22,400 medRxiv, 8,152 bioRxiv)

Most recent first Previous |  Page 692: Articles 6911-6920  | Next

Increased ambulance attendances related to suicide and self-injury in response to the pandemic
John, J., Synn, E. P., Winata, T., Eapen, V., Lin, P.-I.
10.1101/2022.05.29.22273082 — Posted: 2022-05-30
Incidence of Post-Covid Syndrome and Associated Symptoms in Outpatient Care in Bavaria, Germany
Donnachie, E., Hapfelmeier, A., Linde, K., Tauscher, M., Gerlach, R., Greissel, A., Schneider, A.
10.1101/2022.05.29.22275262 — Posted: 2022-05-30
Investigation of a SARS-CoV-2 outbreak in a Texas summer camp resulting from a single introduction
Swetnam, D. M., Alvarado, R. E., Sotcheff, S., Mitchell, B. M., McConnell, A., Machado, R. R. G., Saada, N., Haseltine, F. P., Maknojia, S., Smith, A., Ren, P., Keiser, P., Weaver, S., Routh, A. L.
10.1101/2022.05.29.22275277 — Posted: 2022-05-30
Incidence of SARS-CoV-2 infection among unvaccinated US adults during the Omicron wave
Alejo, J. L., Chiang, T. P.-Y., Mitchell, J., Abedon, A. T., Jefferis, A., Werbel, W. A., Massie, A. B., Makary, M. A., Segev, D. L.
10.1101/2022.05.27.22275630 — Posted: 2022-05-30
Specifying uniform eligibility criteria to strengthen causal inference studies of long-term outcomes of COVID-19
Erqou, S., Zullo, A. R., Jiang, L., Khetpal, V., Berkowitz, J., Shah, N. R., Echouffo-Tcheugui, J. B., Rudolph, J. L., Choudhary, G., Wu, W.-C.
10.1101/2022.05.30.22275733 — Posted: 2022-05-30
Herd immunity on chip: recapitulating virus transmission in human society
LIm, W., Jung, N., Zhang, J., Chen, Z., Weon, B. M., Park, S.
10.1101/2022.05.27.493795 — Posted: 2022-05-30
Potentiating the cross-reactive IFN-γ T cell and polyfunctional T cell responses by heterologous GX-19N DNA booster in mice primed with either a COVID-19 mRNA vaccine or inactivated vaccine
Seo, Y. B., Ko, A., Shin, D., Kim, J., Suh, Y. S., Na, J., Ryu, J. I., Sung, Y. C.
10.1101/2022.05.29.493923 — Posted: 2022-05-30
Monitoring for SARS-CoV-2 drug resistance mutations in broad viral populations
Sedova, M., Jaroszewski, L., Iyer, M., Godzik, A.
10.1101/2022.05.27.493798 — Posted: 2022-05-30
Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro
Yadav, R., Courouble, V. V., Dey, S. K., Harrison, J. J. E. K., Timm, J., Hopkins, J. B., Slack, R. L., Sarafianos, S. G., Ruiz, F. X., Griffin, P. R., Arnold, E.
10.1101/2022.05.27.493767 — Posted: 2022-05-30
Modelling patterns of SARS-CoV-2 circulation in the Netherlands, August 2020-February 2022, revealed by a nationwide sewage surveillance program
van Boven, M., Hetebrij, W. A., Swart, A. M., Nagelkerke, E., van der Beek, R. F., Stouten, S., Hoogeveen, R. T., Miura, F., Kloosterman, A., van der Drift, A.-M. R., Welling, A., Lodder, W. J., de Roda Husman, A. M.
10.1101/2022.05.25.22275569 — Posted: 2022-05-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).